TGF-β and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Gran Via de l'Hospitalet 199, 08908 Barcelona, Spain.
TGF-β and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Gran Via de l'Hospitalet 199, 08908 Barcelona, Spain; Oncology Program, CIBEREHD, National Biomedical Research Institute on Liver and Gastrointestinal Diseases, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Biochim Biophys Acta Gen Subj. 2019 Apr;1863(4):714-722. doi: 10.1016/j.bbagen.2019.01.017. Epub 2019 Jan 29.
The NADPH oxidase (NOX) 4 is an important source of ROS in signal transduction that acts as a liver tumor suppressor. Transforming Growth Factor β (TGF-β) and Epidermal Growth Factor Receptor (EGFR) pathways are involved in the modulation of NOX4 expression. Data showed that recurrent protein deprivation induces changes distinctive of a preneoplastic profile. However, the mechanisms underneath these changes have not been completely understood.
Hepatocytes that survived to the lack of amino acids (Aa) (Sel line) were cultured in complete or Aa free medium. We elucidated the molecular mechanisms that support such preneoplastic alterations employing biochemical and molecular biology assays.
Sel line showed increased phospho-AKT and phospho-ERKs levels, diminished caspase-3 activity, augmented cell proliferation and overactivation of EGFR pathway, reminiscent of a preneoplastic phenotype. NOX4 was upregulated in these cells by TGF-β canonical pathway, however ROS levels were not found increased as a result of an increment of antioxidant enzymes. Inhibition of TGF-β receptor diminished NOX4 and strikingly, after EGFR inhibition, NOX4 levels also decreased. Therefore, both TGF-β and EGFR pathways are shown to be involved in the upregulation of NOX4 in Sel line.
This work provides novel results regarding to the regulation of NOX4 in the preneoplastic transformation of hepatocytes in the absence of Aa, in the context of TGF-β and EGFR pathways.
The advances in the understanding of the molecular mechanisms whose deregulation ultimately causes Hepatocellular Carcinoma (HCC) are essential to prevent it and to design diagnostic biomarkers and therapeutic tools.
NADPH 氧化酶(NOX)4 是信号转导中 ROS 的重要来源,作为一种肝肿瘤抑制因子。转化生长因子 β(TGF-β)和表皮生长因子受体(EGFR)途径参与调节 NOX4 的表达。有数据表明,反复的蛋白质剥夺会引起类似于肝癌前病变特征的变化。然而,这些变化背后的机制尚未完全清楚。
在缺乏氨基酸(Aa)的条件下(Sel 系)培养存活的肝细胞,在完全或无 Aa 的培养基中培养。我们通过生化和分子生物学方法阐明了支持这些肝癌前变化的分子机制。
Sel 系表现出磷酸化 AKT 和磷酸化 ERKs 水平升高、半胱天冬酶-3 活性降低、细胞增殖增加和 EGFR 途径过度激活的特征,类似于肝癌前病变表型。在这些细胞中,NOX4 通过 TGF-β 经典途径上调,但由于抗氧化酶的增加,并未发现 ROS 水平增加。抑制 TGF-β 受体可减少 NOX4,而引人注目的是,在抑制 EGFR 后,NOX4 水平也降低。因此,TGF-β 和 EGFR 途径都被证明参与了 Sel 系中 NOX4 的上调。
本研究为 TGF-β 和 EGFR 途径在无 Aa 条件下肝细胞肝癌前转化中 NOX4 的调控提供了新的结果。
深入了解最终导致肝细胞癌(HCC)的分子机制的调控对于预防 HCC 以及设计诊断生物标志物和治疗工具至关重要。